EU Funding to develop in silico products and services for medicine

An international consortium including Andrew Narracott (Senior Lecturer in the Department of Infection, Immunity & Cardiovascular Disease), Rod Hose, Julian Gunn, John Fenner, Jim Wild and Insigneo members across the Faculties of Medicine and Engineering have been awarded €30 million from Horizon 2020 and national funding sources to establish a Centre for New Methods in Computational Diagnostics and Personalised Therapy.

Dr Andrew Narracott

This will be based in Poland, but Andrew and colleagues will be leading several tasks and a workpackage on development of in silico products and services, with €3million awarded to Sheffield for this work. This is a huge achievement for Andrew and the team and strengthens the important work of Insigneo in transforming medicine.